Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Disease Areas
  • Other Medical News
  • Podcast
  • Videos
  • Education
  • About
    • Vacancies

Tag: Methotrexate

How to treat enthesitis in 2022

Presented By
Prof. Dennis McGonagle, University of Leeds, United Kingdom
Trial
Phase 3, SEAM-PsA, EXCEED, SPIRIT-H2H
Conference
EULAR 2022

21 July, 2022 17:42

Preventive treatment with methotrexate benefits pre-RA patients with arthralgia

Presented By
Dr Doortje Krijbolder, Leiden University Medical Center, the Netherlands
Trial
TREAT EARLIER
Conference
EULAR 2022

21 July, 2022 15:07

New insights into psoriasis comorbidity

Presented By
Prof. Joel Gelfand, University of Pennsylvania, USA
Conference
AAD 2022

17 May, 2022 12:12
Brian

PROTECTing renal transplant recipients from uncontrolled gout

Expert
Dr Brian LaMoreaux, Horizon Therapeutics, Chicago, IL
Trial
Phase 4, PROTECT
Conference
Kidney Week of the American Society of Nephrology

3 February, 2022 23:33

Adding methotrexate to pegloticase nearly doubles gout response rate

Expert
Dr John K Botson, Orthopedic Physicians Alaska, Anchorage
Trial
Phase 3, MIRROR RCT
Conference
ACR 2021

3 February, 2022 08:47

Patients on immunomodulators need 2 COVID-19 vaccinations before seroconversion

Presented By
Dr Ali Al-Janabi, University of Manchester, UK
Conference
PFGC 2021

2 February, 2022 15:22

Pre-existing heart failure affects safety of hydroxychloroquine in RA patients

Presented By
Dr Elvira D’Andrea, Brigham and Women’s Hospital, MA, USA
Conference
ACR 2021

14 January, 2022 11:01

Ustekinumab: highly efficacious in PSA independent of methotrexate

Presented By
Dr Michaela Köhm, Goethe-University Frankfurt, Germany
Conference
ACR 2021

14 January, 2022 10:48

Comparing routes of administration of methotrexate in psoriasis patients

Presented By
Mr Ishan Agrawal, Siksha O Anusandhan University Bhubaneswar, India
Conference
ICD 2021

2 December, 2021 17:24

ICD 2021 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
ICD 2021

29 November, 2021 09:20

Better survival with neoadjuvant dose-dense MVAC regimen in MIBC

Presented By
Dr Christian Pfister, Rouen University Hospital, France
Trial
Phase 3, VESPER
Conference
ESMO 2021

19 November, 2021 09:25

Potential role of inflammation in cardiovascular comorbidity

Presented By
Dr Alexander Egeberg, Herlev and Gentofte Hospital, Denmark
Trial
Phase 3, CANTOS, CIRT
Conference
WPPAC 2021

17 September, 2021 11:13

MATRix with ASCT: best long-term survival for primary CNS lymphoma

Presented By
Dr Gerald Illerhaus, Klinikum der Landeshauptstadt Stuttgart, Germany
Trial
Phase 2, IELSG32
Conference
EHA 2021

5 August, 2021 12:05

Updates on COVID-19 vaccines in patients with rheumatic disease

Presented By
Dr Victoria Furer, Tel Aviv Sourasky Medical Center, Israel
Conference
EULAR 2021

2 August, 2021 22:44

Faecal microbiota transplantation not effective in active peripheral PsA

Presented By
Dr Maja Skov Kragsnaes , University of Southern Denmark, Denmark
Trial
FLORA
Conference
EULAR 2021

2 August, 2021 21:08

TOVERA: Ultrasound is a promising biomarker of early treatment response

Presented By
Dr Maria Stoenoiu, Cliniques Universitaires Saint-Luc, Belgium
Trial
Phase 3, TOVERA
Conference
EULAR 2021

2 August, 2021 21:00

Prognostic factors for minimal disease activity in early psoriatic arthritis revealed

Presented By
Prof. Tatiana Korotaeva, Nasonova Research Institute of Rheumatology, Russia
Conference
EULAR 2021

2 August, 2021 18:13

Psoriasis management in times of COVID-19: the knowledge is growing steadily

Presented By
Prof. Joel Gelfand, University of Pennsylvania Perelman School of Medicine, PA, USA
Conference
AAD VMX 2021

7 June, 2021 13:31

Significant improvements in the system armamentarium for AD treatment

Presented By
Prof. Eric Simpson, Oregon Health & Science University, USA
Conference
AAD VMX 2021

7 June, 2021 13:20

ACE inhibitors associated with superior responses in bladder cancer

Presented By
Dr Jonathan Thomas, Beth Israel Deaconess Medical Centre, Massachusetts, USA
Conference
ASCO GU 2021

24 March, 2021 15:02

Persuasive long-term results for JAK inhibition in rheumatoid arthritis

Presented By
Prof. Josef Smolen, Medical University of Vienna, Austria
Trial
Phase 3, SELECT-MONOTHERAPY
Conference
ACR 2020

18 January, 2021 11:00

Rheumatoid arthritis: new EULAR treatment guidelines

Presented By
Prof. Daniel Aletaha, Medical University Vienna, Austria
Trial
IDEA, NORD-STAR
Conference
ACR 2020

18 January, 2021 11:00

Rheumatoid arthritis and interstitial lung disease: a deadly combination

Presented By
Prof. Joan Bathon, Columbia University, USA
Conference
ACR 2020

18 January, 2021 10:59

Knee osteoarthritis patients with indicators of inflammation could profit from methotrexate

Presented By
Prof. Biswadip Ghosh, Institute of Post Graduate Medical Education and Research, India
Conference
ACR 2020

18 January, 2021 10:48

No elevated risk for influenza AE in tofacitinib-treated RA patients

Conference
ACR 2020

18 January, 2021 10:42

Adalimumab added to methotrexate yields better results in PsA than methotrexate escalatio

Presented By
Dr Laura Coates, Oxford University, United Kingdom
Trial
Phase 4, CONTROL
Conference
EULAR 2020

14 August, 2020 14:09

Psoriasis therapy for children and pregnancies

Presented By
Prof. Mark Lebwohl, Icahn School of Medicine at Mount Sinai, USA
Trial
CRIB, CADMUS, IXORA-PEDS
Conference
AAD 2020

6 August, 2020 08:03

Biologic psoriasis treatment to lower cardiovascular risk?

Presented By
Prof. Joel Gelfand, University of Pennsylvania, USA
Conference
AAD 2020

6 August, 2020 08:01

Hand OA: low-dose corticosteroids improve symptoms

Presented By
Dr Féline Kroon, Prof. Christian Roux
Trial
HOPE
Conference
ACR 2019

4 February, 2020 23:07

Filgotinib promising in RA patients naïve to methotrexate

Presented By
Prof. Rene Westhovens, University of Leuven, Belgium
Trial
Phase 3, FINCH 3
Conference
ACR 2019

4 February, 2020 23:05

Sustained efficacy of monotherapy with upadacitinib after 48 weeks

Presented By
Prof. Joseph Smolen, Medical University of Vienna, Austria
Trial
SELECT-MONOTHERAPY
Conference
ACR 2019

4 February, 2020 22:06

RA patients in remission benefit from continued therapy with conventional DMARDs

Presented By
Dr Siri Lillegraven, Diakonhjemmet Hospital,Norway
Trial
ARCTIC REWIND, TARA
Conference
ACR 2019

4 February, 2020 20:51

Biologics: increasingly used in paediatric dermatology

Presented By
Prof. Marieke Seyger, Radboud University Nijmegen, the Netherlands
Conference
EADV 2019

9 December, 2019 15:16

Cohort study shows improvement during 25 years of RA treatment

Presented By
Dr Xanthe Matthijssen, Leiden University Medical Center, the Netherlands
Conference
EULAR 2019

4 September, 2019 23:13

Filgotinib in RA patients with inadequate response or naïve to methotrexate

Presented By
Prof. Rene Westhovens, University Hospital Leuven, Belgium
Trial
Phase 3, FINCH-3
Conference
EULAR 2019

4 September, 2019 22:35

Clinical effectiveness of fenebrutinib in RA patients with methotrexate or TNFi failure

Presented By
Dr Stanley Cohen, Metroplex Clinical Research Center, Dallas, USA
Conference
EULAR 2019

4 September, 2019 21:38

Peficitinib likely efficacious and safe

Conference
EULAR 2019

4 September, 2019 20:42

Short methotrexate stop is safe in patients with RA

Presented By
Dr Min Jung Kim, Seoul National University Hospital, South Korea
Conference
EULAR 2019

4 September, 2019 19:47

Switching upadacitinib and adalimumab is beneficial in refractory RA

Trial
Phase 3, SELECT-COMPARE
Conference
EULAR 2019

4 September, 2019 17:54

Efficacy and safety of E6011 in RA patients with inadequate response to methotrexate

Presented By
Dr Yoshiya Tanaka, University of Occupational and Environmental Health, Japan
Conference
EULAR 2019

4 September, 2019 15:58

Etanercept and methotrexate as first-line treatment in PsA

Presented By
Prof. Philip Mease, University of Washington, USA
Trial
Phase 3, SEAM-PsA
Conference
EULAR 2019

4 September, 2019 10:40

Advances in target-oriented therapy: psoriatic arthritis

Presented By
Prof. Wolf-Henning Boehncke, University of Geneva, Switzerland
Trial
ECLIPSA, TICOPA
Conference
SPIN 2019

21 June, 2019 23:48

Adalimumab vs adalimumab + methotrexate in psoriasis: First-year results on effectiveness, drug survival, safety, and immunogenicity

Presented By
Dr Gayle van der Kraaij, Amsterdam UMC, the Netherlands
Conference
SPIN 2019

21 June, 2019 20:57

Small molecules, apremilast, and TYK2

Presented By
Prof. Richard Langley, Dalhousie University, Canada
Trial
ESTEEM, PALACE, LIBERATE
Conference
SPIN 2019

21 June, 2019 09:45

Early, intensive rheumatoid arthritis treatment seems to normalise mortality rates

Trial
COBRA
Conference
EULAR 2018

24 August, 2018 23:36

Combining new drugs with different mechanisms

Trial
EXPLORER
Conference
ECCO 2018

28 May, 2018 23:31

Targeting early disease: lessons from rheumatoid arthritis

Trial
OPTIMA
Conference
ECCO 2018

28 May, 2018 19:27

Targeting early disease: lessons from rheumatoid arthritis


28 May, 2018 19:19
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy